UW Vaccine & Treatment Evaluation Unit

Research Opportunities


April 5, 2022

COVAIL Trial: Help Fight What’s Next

Phase 2 Additional COVID-19 Vaccine Booster Trial The University of Washington is seeking volunteers for the COVID-19 VAriant Immunologic Landscape (COVAIL) Trial, a phase 2 additional COVID-19 vaccine booster trial. The purpose of this clinical trial is to test the safety and effectiveness of additional COVID-19 booster doses in people who have already received a…


July 12, 2021

Updated 03/14/2022: “Mix ‘n Match” Booster COVID-19 Vaccine Clinical Trial

The University of Washington is seeking volunteers for a Phase 1/2 COVID-19 vaccine booster trial to test the safety and effectiveness of additional doses of EUA vaccines in people who have received an EUA vaccine series.


April 21, 2021

Gritstone COVID-19 Vaccine Clinical Trial

Updated March 2022 The University of Washington Virology Research Clinic (VRC)/Vaccine & Treatment Evaluation Unit (VTEU) is conducting a clinical trial of a chimpanzee Adenovirus and self-amplifying mRNA prime-boost prophylactic vaccines against SARS-CoV-2 in healthy adults. The purpose of this trial is to test investigational booster vaccines for COVID-19. Participants who previously received a two-dose series…


December 28, 2020

Novavax COVID-19 Vaccine Trial (no longer enrolling)

We are currently enrolling members of the public in a clinical trial of a Phase 3 vaccine for the prevention of COVID-19. Our research site is testing the SARS-CoV-2 recombinant spike protein nanoparticle vaccine that is now being developed as part of Operation Warp Speed by a new NIH network – the Coronavirus Prevention Network, or…